Status:
COMPLETED
Tranexamic Acid in Abdominoplasty.
Lead Sponsor:
Poznan University of Medical Sciences
Conditions:
Abdominal Wall Defect
Hemorrhage
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The investigators prepared a novel tranexamic acid (TXA) study designed to estimate the quantity of blood loss in patients undergoing abdominoplasty surgery. This study aims to quantify blood loss dur...
Detailed Description
Tranexamic acid (TXA) treatment is increasingly emphasized in plastic surgery because TXA inhibits fibrinolysis. Increased clot stability offers the possibility of preventing blood loss (prevention) a...
Eligibility Criteria
Inclusion
- Scheduled abdominoplasty
- ASA 1 or 2
- age \>18 and \<75 years
Exclusion
- BMI \<20 or \>35 kg/m2
- ASA 3 or \> 3
- medical history of thromboembolism
- history of hematological disease
- treatment with aspirin 14 days before the procedure
- treatment with anticoagulants 5 days before the procedure
- epilepsy
- allergy to tranexamic acid
- coagulation disorders
Key Trial Info
Start Date :
October 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06086444
Start Date
October 17 2023
End Date
October 10 2025
Last Update
November 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poznan University of Medical Sciences
Poznan, Poznań, Poland, 61-701